f5 tcr transgenic cells
Cell therapyexperimental
Clinical trial activity
1 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2009 (NCT00910650)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Influenza A virusImmunity, passive
Influenza A virus immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- f5 tcr transgenic cells
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00910650 | Phase 2 | Oct 1, 2009 | California Institute of Technology, National Cancer Institute (NCI), University of California, Los Angeles, University of Connecticut, University of Southern California |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| California Institute of Technology | Academic/Hospital | 1 | 0 | 1 | 2009 |
| National Cancer Institute (NCI) | Government | 1 | 0 | 1 | 2009 |
| University of California, Los Angeles | Academic/Hospital | 1 | 1 | 1 | 2009 |
| University of Connecticut | Academic/Hospital | 1 | 0 | 1 | 2009 |
| University of Southern California | Academic/Hospital | 1 | 0 | 1 | 2009 |
5 organizations
Page 1 / 1